Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

Conservative Treatment with Octreotide as an Adjunct for Chylothorax after Lung Cancer Surgery - Two Cases

폐암 수술 후 발생한 유미흉의 옥트레오타이드를 이용한 보존적 치료 -2예 보고-

  • Song Suk-Won (Center for Lung Cancer, Research Institute and Hospital, National Cancer Center) ;
  • Lee Hyun-Sung (Center for Lung Cancer, Research Institute and Hospital, National Cancer Center) ;
  • Kim Moon-Soo (Center for Lung Cancer, Research Institute and Hospital, National Cancer Center) ;
  • Lee Jong-Mog (Center for Lung Cancer, Research Institute and Hospital, National Cancer Center) ;
  • Kim Jae-Hyun (Center for Lung Cancer, Research Institute and Hospital, National Cancer Center) ;
  • Zo Jae-Ill (Center for Lung Cancer, Research Institute and Hospital, National Cancer Center)
  • 송석원 (국립암센터 폐암센터 흉부외과) ;
  • 이현성 (국립암센터 폐암센터 흉부외과) ;
  • 김문수 (국립암센터 폐암센터 흉부외과) ;
  • 이종목 (국립암센터 폐암센터 흉부외과) ;
  • 김재현 (국립암센터 폐암센터 흉부외과) ;
  • 조재일 (국립암센터 폐암센터 흉부외과)
  • Published : 2006.07.01
Download PDF
⟨ Previous Next ⟩

Abstract

Postoperative chylothorax is a rare but serious complication of thoracic surgical procedures. We report two cases of chylothorax after lobectomy and mediastinal Iymph node dissection for lung cancer. The patients were successfully treated with subcutaneous octreotide injection as an adjunct to conservative treatment.

폐절제술 후 발생하는 유미흉은 드물지만 심각한 합병증이다. 두 명의 폐암 환자에서 폐엽 절제술 및 종격동 림프절 청소술 후에 유미흉이 발생하였으나, 고전적 보존적 치료에 피하 옥트레오타이드 주사 요법을 추가하여 성공적으로 치료하였다.

Keywords

References

  1. Cerfolio RJ, Allen MS, Deschamps C, Trastek VF, Pairolero PC. Postoperative chylothorax. J Thorac Cardiovasc Surg 1996;112:1361-5 https://doi.org/10.1016/S0022-5223(96)70152-6
  2. Kimihiro S, Junji Y, Mituyo N, Kazuya T, Rie N, Kanji N. Treatment strategy for chylothorax after pulmonary resection and lymph node dissection for lung cancer. J Thorac Cardiovasc Surg 2002;124:499-502 https://doi.org/10.1067/mtc.2002.124386
  3. de Beer HGJ, Mol MJT, Janssen JP. Chylothorax. Neth J Med 2000;56:25-31 https://doi.org/10.1016/S0300-2977(99)00114-X
  4. Le Coultre C, Oberhansli I, Mossaz A, Bugmann P, Faidutti B, Belli DC. Postoperative chylothorax in children: differences between vascular and traumatic origin. J Pediatr Surg 1991;26:519-23 https://doi.org/10.1016/0022-3468(91)90696-Q
  5. Bac DJ, Van Hagen PM, Postema PTE, ten Bokum AMC, Zondervan PE, van Blankenstein M. Octreotide for proteinlosing enteropathy with intestinal lymphangiectasia. Lancet 1995;345:1639 https://doi.org/10.1016/S0140-6736(95)90145-0
  6. Grosman I, Simon D. Potential gastrointestinal uses of somatostatin and its synthetic analogue octreotide. Am J Gastroenterol 1990;85:1061-72
  7. Cheung Y, Leung MP, Yip M. Octreotide for treatment of postoperative chylothorax. J Pediatr 2001;139:157-9 https://doi.org/10.1067/mpd.2001.115572
  8. Ulibarri JI, Sanz Y, Fuentes C, Mancha A, Aramendia M, Sanchez S. Reduction of lymphorrhagia from ruptured thoracic duct by somatostatin. Lancet 1990;339:258